Related Experiment Video

Updated: May 8, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes

Karine M De Amicis1, Samar Freschi de Barros1, Raquel E Alencar1

  • 1Heart Institute (InCor), School of Medicine, University of Sao Paulo, Sao Paulo, Brazil; Immunology Investigation Institute, National Institute for Science and Technology, University of Sao Paulo, Sao Paulo, Brazil.

Vaccine
|September 3, 2013
PubMed

Insights

This study shows StreptInCor vaccine candidate effectively neutralizes Streptococcus pyogenes strains, preventing infections and autoimmune reactions. Immunization induces protective antibodies against common strains.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Streptococcus pyogenes causes severe infections like pharyngitis, sepsis, and toxic shock syndrome.
  • The M protein is a key bacterial antigen, with conserved and polymorphic regions.

Purpose of the Study:

  • To evaluate the in vitro efficacy of StreptInCor, a C-terminal candidate vaccine against S. pyogenes.
  • To assess antibody induction for neutralizing/opsonizing common S. pyogenes strains in Sao Paulo.
  • To investigate potential cross-reactivity with human heart valve tissue.

Main Methods:

  • Sera from StreptInCor-immunized mice were used to examine antibody recognition.
  • In vitro assays were performed to assess neutralization and opsonization capabilities.
  • Cross-reactivity against human heart valve tissue was evaluated.

Main Results:

  • Anti-StreptInCor antibodies demonstrated the ability to neutralize/opsonize at least five common S. pyogenes strains.
  • Immunization proved effective against multiple S. pyogenes strains.
  • No autoimmune reactions were observed, indicating safety.

Conclusions:

  • StreptInCor is a promising vaccine candidate against S. pyogenes.
  • Effective immunization can prevent S. pyogenes infections and associated sequelae.
  • The vaccine candidate shows potential for safe and broad-spectrum protection.
Keywords:
Immune responseImmunization coverageRheumatic feverStreptococcus pyogenesVaccine

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...